Papers

2

Total Citations

24

H-Index

2

About

Dr. Hersh Trivedi is a urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques, particularly in the treatment of benign prostatic hyperplasia (BPH). His major contributions lie in evaluating the outcomes of robotic-assisted simple prostatectomy, with a focus on optimizing patient recovery and reducing opioid use. In his landmark 2021 study, "Single-port robotic-assisted simple prostatectomy is associated with decreased post-operative narcotic use in a propensity score matched analysis" (22 citations), Dr. Trivedi demonstrated that single-port robotic surgery significantly lowers postoperative narcotic requirements compared to traditional approaches, highlighting its potential to mitigate the opioid crisis. His subsequent 2022 work, "Evaluating Surgical Outcomes of Robot Assisted Simple Prostatectomy in the Retreatment Setting" (2 citations), further explores the safety and efficacy of robotic techniques in complex cases requiring repeat intervention. By systematically analyzing surgical outcomes, Dr. Trivedi provides evidence that supports the broader adoption of robotic-assisted procedures, ultimately aiming to enhance patient quality of life and reduce healthcare burdens. His research is a vital resource for urologists and trainees seeking to integrate cutting-edge, patient-centered surgical innovations into clinical practice.

Research Focus

Key Achievements

2
H-Index
2
Papers
24
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Single-port robotic-assisted simple prostatectomy is associated with decreased post-operative narcotic use in a propensity score matched analysis
22 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: The University of Texas Southwestern Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago